A major breakthrough in cancer study is emerging with the use of mini-antibodies to restore dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many forms of malignancies, resulting https://thekiwisocial.com/story7563033/vhh-fragments-revive-p53-new-promising-hope-for-cancer-treatment